Kinetic evaluation in nonhuman primates of two new PET ligands for peripheral benzodiazepine receptors in brain

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Synapse

• Publication date

  2007-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/SYN.20394PMID 17455247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PET imaging of the dopamine transporter with 18F-FECNT: a polar radiometabolite confounds brain radioligand measurements.

  2006cited by this paper
• Quantitative analyses of 18F-FEDAA1106 binding to peripheral benzodiazepine receptors in living human brain.

  2006cited by this paper
• Intrinsic Activated Microglia Map to the Peri-infarct Zone in the Subacute Phase of Ischemic Stroke

  2006cited by this paper
• Microglial activation and dopamine terminal loss in early Parkinson's disease

  2005cited by this paper
• Development of a new radioligand, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide, for pet imaging of peripheral benzodiazepine receptor in primate brain.

  2004cited by this paper
• Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study.

  2004cited by this paper
• Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: An imaging tool for glial cells in the brain

  2004influential reference
• Design, synthesis and structure-affinity relationships of aryloxyanilide derivatives as novel peripheral benzodiazepine receptor ligands.

  2004cited by this paper
• PET visualization of microglia in multiple sclerosis patients using [11C]PK11195

  2003cited by this paper
• [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy

  2003cited by this paper
• [(11)C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain.

  2003cited by this paper
• Neuropathological imaging: in vivo detection of glial activation as a measure of disease and adaptive change in the brain.

  2003cited by this paper
• In vivo imaging of neuroinflammation.

  2002influential reference
• Visualising microglial activation in vivo

  2002cited by this paper
• In-vivo measurement of activated microglia in dementia.

  2001cited by this paper
• In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion.

  2001cited by this paper
• Modulation of GABAergic synaptic transmission by the non-benzodiazepine anxiolytic etifoxine.

  2000cited by this paper
• The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity.

  2000cited by this paper
• Sporadic Creutzfeldt-Jakob disease: Co-occurrence of different types of PrPSc in the same brain

  1999cited by this paper
• Peripheral-Type Benzodiazepine Receptor

  1999cited by this paper
• Binding characteristics of [3H]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors.

  1999cited by this paper
• Peripheral benzodiazepine receptor agonists exhibit potent antiapoptotic activities.

  1999cited by this paper
• Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106.

  1999cited by this paper
• Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis.

  1997cited by this paper
• Benzodiazepines, anxiety and immunity.

  1997cited by this paper
• PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease.

  1995cited by this paper
• Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier.

  1992cited by this paper
• Brain kinetics and specific binding of [11C]PK 11195 to omega 3 sites in baboons: positron emission tomography study.

  1991influential reference
• Peripheral type benzodiazepine receptors.

  1989cited by this paper
• Labelling of peripheral-type benzodiazepine binding sites in human brain with [3H]PK 11195: anatomical and subcellular distribution.

  1987cited by this paper
• Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart

  1987cited by this paper
• Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage.

  1987influential reference
• The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane.

  1986cited by this paper
• Effects of Temporal Sampling, Glucose Metabolic Rates, and Disruptions of the Blood—Brain Barrier on the FDG Model with and without a Vascular Compartment: Studies in Human Brain Tumors with PET

  1986cited by this paper
• Evidence for species differences in 'peripheral' benzodiazepine receptors: an autoradiographic study.

  1986influential reference
• Peripheral-type benzodiazepine receptors in the central nervous system: localization to olfactory nerves

  1984cited by this paper
• Labelling of “Peripheral‐Type” Benzodiazepine Binding Sites in the Rat Brain By Using [3H]PK 11195, an Isoquinoline Carboxamide Derivative: Kinetic Studies and Autoradiographic Localization

  1983cited by this paper
• Specific high-affinity binding sites for [3H]Ro 5-4864 in rat brain and kidney.

  1983cited by this paper
• A new look at the statistical model identification

  1974cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973influential reference

• The development status of PET radiotracers for evaluating neuroinflammation

  2024cites this paper
• Targeting the Translocator Protein (18 kDa) in Cardiac Diseases: State of the Art and Future Opportunities

  2023cites this paper
• Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [18F]LW223 as a TSPO-targeted PET radioligand.

  2023cites this paper
• Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica

  2022cites this paper
• The 18-kDa Translocator Protein PET Tracers as a Diagnostic Marker for Neuroinflammation: Development and Current Standing

  2022cites this paper
• Essential Principles and Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging.

  2022cites this paper
• GMP-compliant fully automated radiosynthesis of [18F]FEPPA for PET/MRI imaging of regional brain TSPO expression

  2021cites this paper
• In Vivo Brain Region-specific TSPO Imaging by PET/MRI [18F]FEPPA

  2020cites this paper
• Recent developments on PET radiotracers for TSPO and their applications in neuroimaging

  2020cites this paper
• EVALUATION OF NOVEL RADIOPHARMACEUTICALS FOR POSITRON EMISSION TOMOGRAPHY IMAGING OF ANIMAL MODELS OF MULTIPLE SCLEROSIS

  2020cites this paper
• Comparison of high and low molar activity TSPO tracer [18F]F-DPA in a mouse model of Alzheimer’s disease

  2020cites this paper
• Huntington’s Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers

  2020cites this paper
• Thalamic neuroinflammation as a reproducible and discriminating signature for chronic low back pain.

  2020cites this paper
• Image Fusion in Preclinical Applications

  2019cites this paper
• 18F-PBR06 PET/CT imaging of inflammation and differentiation of lung cancer in mice

  2019cites this paper
• 18F-PBR06 PET/CT imaging for evaluating atherosclerotic plaques linked to macrophage infiltration

  2019cites this paper
• 18F-PBR06 PET/CT imaging of inflammation and differentiation of lung cancer in mice

  2019cites this paper
• TSPO–PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington’s disease: preclinical evidence with the p75NTR ligand LM11A-31

  2018cites this paper
• 11C-DPA-713 Versus 18F-GE-180: A Preclinical Comparison of Translocator Protein 18 kDa PET Tracers to Visualize Acute and Chronic Neuroinflammation in a Mouse Model of Ischemic Stroke

  2018cites this paper
• Application of molecular imaging technology in neurotoxicology research

  2018cites this paper
• Test-retest reliability and convergent validity of (R)-[11C]PK11195 outcome measures without arterial input function

  2018cites this paper
• Multimodality Preclinical Imaging in Inflammatory Diseases

  2018cites this paper
• Sifting through the surfeit of neuroinflammation tracers

  2017cites this paper
• Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging in Neurological Diseases

  2017cites this paper
• Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [18F]PBR102 and [18F]PBR111

  2017cites this paper
• Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.

  2016cites this paper
• Neural Substrates of Parkinson's Disease

  2016cites this paper
• Quantitative analysis of positron emission tomography (PET) with the second generation translocator protein (TSPO) ligand [18F]GE-180

  2016cites this paper
• Improved Automated Radiosynthesis of [11C]PBR28

  2015cites this paper
• [18F]DPA-714 PET imaging of translocator protein TSPO (18 kDa) in the normal and excitotoxically-lesioned nonhuman primate brain

  2015cites this paper
• Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use

  2015cites this paper
• PET radioligands for in vivo visualization of neuroinflammation.

  2014cites this paper
• An improved, regioselective synthesis of the radiolabelling precursor for the translocator protein targeting positron emission tomography imaging radiotracer [18F]GE-180

  2014cites this paper
• Radiosynthesis and ex vivo evaluation of [(11)C-carbonyl]carbamate- and urea-based monoacylglycerol lipase inhibitors.

  2014cites this paper
• The development of an automated and GMP compliant FASTlab™ Synthesis of [(18) F]GE-180; a radiotracer for imaging translocator protein (TSPO).

  2014cites this paper
• A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation

  2013cites this paper
• In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.

  2013cites this paper
• Investigation of the Effects of Image Signal-to-Noise Ratio on TSPO PET Quantification of Neuroinflammation

  2013cites this paper
• Exploration of the structure-activity relationship of a novel tetracyclic class of TSPO ligands-potential novel positron emitting tomography imaging agents.

  2013cites this paper
• Increased In Vivo Expression of an Inflammatory Marker in Temporal Lobe Epilepsy

  2012cites this paper
• Exploration of the structure-activity relationship of the diaryl anilide class of ligands for translocator protein--potential novel positron emitting tomography imaging agents.

  2012cites this paper
• Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects.

  2012cites this paper
• GAS-PHASE ELECTROCHEMICAL DETECTION OF TRACE ARSENIC IN DRINKING WATER

  2012cites this paper
• [¹⁸F]GE-180: a novel fluorine-18 labelled PET tracer for imaging Translocator protein 18 kDa (TSPO).

  2012cites this paper
• Comparison of 18F- and 11C-labeled aryloxyanilide analogs to measure translocator protein in human brain using positron emission tomography

  2011cites this paper
• Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET study

  2011cites this paper
• Variation in binding affinity of the novel anxiolytic XBD173 for the 18 kDa translocator protein in human brain

  2011cites this paper
• Synthesis of 6-[¹⁸F]fluoro-PBR28, a novel radiotracer for imaging the TSPO 18 kDa with PET.

  2011cites this paper
• Quantitative, Preclinical PET of Translocator Protein Expression in Glioma Using 18F-N-Fluoroacetyl-N-(2,5-Dimethoxybenzyl)-2-Phenoxyaniline

  2011cites this paper
• USE OF 18 FDG-PET IMAGING TO PREDICT TREATMENT RESPONSE TO IGF-1 R / IR TARGETED THERAPY IN LUNG CANCER

  2011cites this paper
• PET-Derived Biodistribution and Dosimetry of the Benzodiazepine Receptor-Binding Radioligand 11C-(R)-PK11195 in Children and Adults

  2010cites this paper
• PET tracers for the peripheral benzodiazepine receptor and uses thereof.

  2010cites this paper
• Fluorine-18 chemistry in micro-reactors.

  2010cites this paper
• The development of PET radioligands for imaging the translocator protein (18 kDa): What have we learned?

  2010cites this paper
• Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of Neuroinflammation

  2010influential citation
• Biodistribution and Radiation Dosimetry in Humans of a New PET Ligand, 18F-PBR06, to Image Translocator Protein (18 kDa)

  2010cites this paper
• Radiolabelled molecules for imaging the translocator protein (18 kDa) using positron emission tomography.

  2009cites this paper
• A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system.

  2009cites this paper
• Single-step high-yield radiosynthesis and evaluation of a sensitive 18F-labeled ligand for imaging brain peripheral benzodiazepine receptors with PET.

  2009cites this paper
• Quantification of Translocator Protein (18 kDa) in the Human Brain with PET and a Novel Radioligand, 18F-PBR06

  2009influential citation
• Advances in the molecular imaging of multiple sclerosis

  2009cites this paper
• Synthesis and biological evaluation of substituted [18F]imidazo[1,2-a]pyridines and [18F]pyrazolo[1,5-a]pyrimidines for the study of the peripheral benzodiazepine receptor using positron emission tomography.

  2008cites this paper
• Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo.

  2008cites this paper
• Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation

  2008cites this paper
• Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors.

  2008cites this paper
• Kinetic analysis in healthy humans of [11C]PBR28, a new positron emission tomography radioligand to image the peripheral benzodiazepine receptor

  2008cites this paper
• PET imaging of the peripheral benzodiazepine receptor: monitoring disease progression and therapy response in neurodegenerative disorders.

  2008cites this paper
• In vivo imaging of microglial activation using a peripheral benzodiazepine receptor ligand: [11C]PK-11195 and animal PET following ethanol injury in rat striatum

  2008cites this paper
• Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors

  2008influential citation
• 11C-Loperamide and Its N-Desmethyl Radiometabolite Are Avid Substrates for Brain Permeability-Glycoprotein Efflux

  2008cites this paper
• Increased peripheral benzodiazepine receptors in arterial plaque of patients with atherosclerosis: an autoradiographic study with [(3)H]PK 11195.

  2008cites this paper
• Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers

  2008cites this paper
• Radiation Dosimetry and Biodistribution in Monkey and Man of 11C-PBR28: A PET Radioligand to Image Inflammation

  2007cites this paper
• Loperamide and its N-desmethyl radiometabolite are avid substrates for brain P-glycoprotein efflux

  2007cites this paper
• Where there is depression, there is inflammation... sometimes!

  2007cites this paper